Dominic Clarke

Chief Technical Officer, Cell and Gene Therapy • Discovery Life Sciences

Dr. Clarke brings more than 15 years of cell and gene related experience to Discovery.  He is the acting chair for the International Society for Cell and Gene Therapies (ISCT) Process and Product Development Committee – a global industry leadership forum directed toward translating research and process development from bench to clinic through education and guidance.  Prior to joining Discovery, he served as Global Head of Cell Therapy for HemaCare, a Charles River company.  During his tenure there, he developed and led the company’s global cell therapy corporate strategy, provided scientific and technical expertise both operationally and commercially, and spearheaded innovation across the organization.

Also Speaking

Michael Lawlor

Professor • Medical College of Wisconsin

Lisa Ward

Co-Founder • Tough2gether Against DIPG/DMG

Lisa McClain-Moss

Vice President, Manufacturing • Longeveron

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.